New diabetes clinical trial: GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
Published on: June 28, 2021 at 09:30PM
Conditions: Palliative Care; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Diabetes; Cancer; Terminal Cancer; Terminal Illness; End Stage Cancer; Advanced Cancer
Interventions: Device: Continuous Glucose Monitoring; Device: Standard Care
Sponsors: Antea Foundation; Abbott Diabetes Care
Not yet recruiting
https://ift.tt/3w3SZkT
Conditions: Palliative Care; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Diabetes; Cancer; Terminal Cancer; Terminal Illness; End Stage Cancer; Advanced Cancer
Interventions: Device: Continuous Glucose Monitoring; Device: Standard Care
Sponsors: Antea Foundation; Abbott Diabetes Care
Not yet recruiting
https://ift.tt/3w3SZkT
Comments
Post a Comment